Legal Representation
Attorney
Karen Lim
USPTO Deadlines
Next Deadline
2099 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-22)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 22, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Apr 22, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 11, 2025 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Feb 10, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 10, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 10, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 9, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Dec 26, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
Dec 26, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Dec 26, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Dec 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 22, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 22, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
Oct 22, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 11, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Jun 25, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 25, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, pharmaceutical preparations for use in immunology, antibodies for medical use; pharmaceutical preparations for the prevention and treatment of respiratory and inflammatory diseases and disorders, vaccines for human use.
Classification
International Classes
005